Boothbay Fund Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Boothbay Fund Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.6K	Hold	1,627	–	–	﹤0.01%	1928
2025 Q4	$47.2K	Sell	1,627 -502	-24%	-$10.1K	﹤0.01%	1827
2025 Q3	$35.7K	Hold	2,129	–	–	﹤0.01%	1804
2025 Q2	$176K	Buy	+2,129	New	+$138K	﹤0.01%	1265
2020 Q3	–	Sell	-13	Closed	-$78K	–	1238
2020 Q2	$78K	Buy	+13	New	+$88K	0.01%	898
2018 Q4	–	Sell	-9	Closed	-$315K	–	912
2018 Q3	$315K	Buy	+9	New	+$278K	0.03%	487

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Boothbay Fund Management's YARW Position: Q1 2026 in Review

Boothbay Fund Management held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2026 at 1,627 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Boothbay Fund Management first reported a position in YARW in Q3 2018 and has held it in 6 quarters since. The position peaked at $315K in Q3 2018. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

Boothbay Fund Management held 1,627 shares of Yarrow Bioscience, Inc. Common Stock worth $48.6K as of Q1 2026.
Boothbay Fund Management left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2026.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1928 holding.
Boothbay Fund Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and has held it in 6 quarters since.
Boothbay Fund Management's Yarrow Bioscience, Inc. Common Stock position peaked at $315K in Q3 2018.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.